SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-030729
Filing Date
2017-05-08
Accepted
2017-05-08 17:18:10
Documents
7
Period of Report
2017-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-12172_78k.htm 8-K 38016
2 EX-1.1 a17-12172_7ex1d1.htm EX-1.1 290390
3 EX-5.1 a17-12172_7ex5d1.htm EX-5.1 14965
4 EX-99.1 a17-12172_7ex99d1.htm EX-99.1 14260
5 EX-99.2 a17-12172_7ex99d2.htm EX-99.2 15955
6 GRAPHIC g121727mmi001.jpg GRAPHIC 5640
7 GRAPHIC g121727moi001.jpg GRAPHIC 4673
  Complete submission text file 0001104659-17-030729.txt   389287
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 17823462
SIC: 2834 Pharmaceutical Preparations